Dalman, Teodora A.

HRN: 09-58-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2023
CEFTRIAXONE 1G (VIAL)
06/08/2023
06/15/2023
IV
2g
OD
Urosepsis
Waiting Final Action 
06/10/2023
AZITHROMYCIN 500MG TABLET (TAB)
06/10/2023
06/14/2023
PO
500mg
OD
CAP MR
Waiting Final Action 
06/12/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/12/2023
06/12/2023
IV
4.5
LD
Urosepsis
Waiting Final Action 
06/12/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/12/2023
06/19/2023
IV
2.25
Q12
Urosepsis
Waiting Final Action 
06/15/2023
MUPIROCIN 2%, 15G (TUBE)
06/15/2023
06/21/2023
TOPICAL
Ample Amount
BID
Infected Wound
Waiting Final Action 
06/17/2023
MUPIROCIN 2%, 15G (TUBE)
06/17/2023
06/24/2023
TOPICAL
Sufficient Amount
BID
Infected Wound
Waiting Final Action 
06/19/2023
LEVOFLOXACIN 500MG (TAB)
06/19/2023
06/26/2023
PO
500mg
OD
Complicated Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: